Promethera Biosciences Competitors and Similar CompaniesClear all
Intercept Pharmaceuticals's competitors and similar companies include Genfit.
 Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. |  Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 2002 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 58321% increase | Employees 180 |
Valuation ($) | Valuation ($) 794.7 m | Valuation ($) 280.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) €65.4m (FY, 2025) |
Cost of goods | Cost of goods $984k (FY, 2022) | Cost of goods €302k (FY, 2025) |
Gross profit | Gross profit $284.7m (FY, 2022) | Gross profit €70.8m (FY, 2025) |
Net income | Net income $221.8m (FY, 2022) | Net income (€86m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Genfit
HQ
Loos, FR
Employees
180
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company